Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema–Systematic review, meta-analysis and meta-regression

BACKGROUND: The most frequent cause of vision loss from diabetic retinopathy is diabetic macular edema (DME). Earlier clinical trials tried to examine the role of intravitreal triamcinolone (IVT) and intravitreal bevacizumab (IVB) in DME; they either qualified IVT over IVB or IVB over IVT or did not...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Maboud, Mohamed, Menshawy, Esraa, Bahbah, Eshak I., Outani, Oumaima, Menshawy, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802957/
https://www.ncbi.nlm.nih.gov/pubmed/33434220
http://dx.doi.org/10.1371/journal.pone.0245010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802957/
https://www.ncbi.nlm.nih.gov/pubmed/33434220
http://dx.doi.org/10.1371/journal.pone.0245010

Ejemplares similares